【摘 要】
：
Background: The aim of this study was to determine whether the concentration of disintegrin and metalloprotease proteinl2 (ADAM12) in first trimester maternal serum can be used as a marker for first-t
【机 构】
：
Prenatal Diagnosis Centre, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China
【出 处】
：
广东省遗传学会第九届代表大会暨学术研讨会
论文部分内容阅读
Background: The aim of this study was to determine whether the concentration of disintegrin and metalloprotease proteinl2 (ADAM12) in first trimester maternal serum can be used as a marker for first-trimester complete spontaneous abortions, missed abortions, ectopic pregnancies and hydatidiform moles.Methods : The maternal serum concentrations of ADAM12 were measured in the range of 5-9+6 weeks of gestation using an automated AutoDelfia immunoassay platform in 9 cases of complete spontaneous abortion, 27 cases of missed abortions, 56 cases of ectopic pregnancies, 12 cases of hydatidiform moles, and 100 controls.Logistic regression analysis was used to determine significant factors for predicting adverse pregnancyoutcomes in early pregnancy.Screening performance was assessed using receiver operating characteristic curves.Results: Two hundred and four women were enrolled in the study.In the control group, the level of ADAM12 increased with gestational age.The median ADAM12 levels in the spontaneous abortion (0.430 MoM), ectopic pregnancy (0.460 MoM) and hydatidiform mole (0.037 MoM) groups were lower than that in the control group, while the median ADAM12 level in the missed abortion group (1.062 MoM) was not significant from the controls (1.002 MoM).Logistic regression analysis demonstrated that the level of ADAM12 in maternal serum facilitated the detection of ectopic pregnancies (OR =0.909;95% CI =0.841-0.982) and complete spontaneous abortion (OR =0.863;95% CI =0.787-0.946).Conclusions: In complete spontaneous abortion and ectopic pregnancy, ADAM12 maintained at low levels in early pregnancies, and there were significant differences compared to normal pregnancies.ADAM12 is a promising marker for the diagnosis of complete spontaneous abortion and ectopic pregnancy in symptomatic women, and under certain conditions, ADAM12 can diagnose ectopic pregnancy and spontaneous abortion before an ultrasonographic detection of the conditions.
其他文献
In single molecule localization based supper resolution microscopy, center position of activated fluorescent maker can be localized by fitting with single point spread function(PSF)or multiple PSFs.Th
Pediatric dose measurements during radiographic examinations are of special concern due to the fact that pediatric are more radiosensitive than adults due to their rapidly growing tissue and their lon
Dihydrofolate reductase (DHFR) is a household enzyme that is responsible for the NADPH-dependent conversion of dihydrofolate (DHF) to tetrahydrofolate (THF).The mechanism involves proton donation at N
Alkyl, as a bioorthogonal chemical reporter, can be metabolically incorporated into biomolecules including nucleic acids, proteins, lipids, and glycans.In addition to the clickable chemical reactivity
Objective Aim to provide an effective genetic testing for thalassemia (thal) , we analyzed genotype α and β-globin, as well as the polymorphism of β-globin gene in Cantonese in recent years.Methods Us
目的 通过体外实验探讨铂耐药的上皮性卵巢癌细胞中是否存在Notch信号通路异常激活及EMT样表型的获得,并探讨γ-分泌酶抑制剂对化疗耐药EOC增殖、粘附、侵袭、转移等生物学行为的影响,为卵巢癌治疗提供新思路.方法 体外培养人卵巢浆液性囊腺癌细胞株SKOV3及其顺铂耐药株SKOV3/DDP,PCR检测其Notch1 mRNA表达量的差异,western-blot检测γ分泌酶抑制剂DAPT作用于SKO
目的 通过超声引导下介入性穿刺术获取胎儿附属物标本进行遗传性耳聋基因产前诊断,降低遗传性耳聋患儿的出生率.方法 孕11～13+6周孕妇采用超声引导下绒毛活检术抽取胎盘绒毛；孕18～24+6周孕妇在超声引导下抽取羊水,孕24周以上孕妇在超声引导下抽取脐血.应用短串重复序列连锁分析(STR)进行母血污染鉴别,遗传性耳聋基因芯片检测技术对GJB2、GJB3、SLC26A4和mtDNA12SrRNA四个耳
线粒体tRNA基因是原发性高血压(Essential hypertension,EH)的突变热点区.文章报道了3个携带线粒体tRNAGIn 4363T＞C突变的、具有母系遗传特征的原发性高血压家系的分子遗传学特征.3个家系的临床数据分析表明,3个家系母系成员的外显率为23.5％,非母系成员的外显率为2％,具有统计学差异(P＜0.01),呈现母系遗传特征.线粒体全序列分析显示,3位先证者均携带同质性
Background: Obtaining fetal DNA or RNA by either chorionic villus sampling (CVS) or amniocentesis is currently, the gold standard prenataldiagnosis.However, these invasive procedures carry risk of mis
Background: The noninvasive prenatal diagnosis procedures that are currently used to detect genetic diseases do not achieve desirable levels of sensitivity and specificity.Recently, fetal methylated D